The European Medicine Agency (EMA) wanted to explore the possibility of mixed use of two vaccines from the coronavirus at once. About this in an interview with the newspaper La Stampa, the head of the Department of Definitions of Health and Vaccination Strategies Marco Cavalery was stated.
“We do not expect problems in terms of safety, although there are no major research on this topic, careful control will be required,” Kavalery noted, adding practical research in this area.
Previously, the Spanish Health Institute Carlos III was engaged in this question. According to its research, the simultaneous introduction of two vaccines: from Pfizer and Biontech, as well as from Astrazeneca safe for patient health.
In turn, the Roman National Institute of Infectious Diseases named after Ladzaro Spallazeni announced research on the safety and efficiency of the use of the Russian Satellite Vaccine, along with drugs approved by EMA.